Tag FDA

Massachusetts-based biotechnology firm KnipBio is the first single-cell protein manufacturer serving the aquafeed industry to earn Generally Regarded as Safe designation from the U.S. Food and Drug Administration. 

La legislación de la UE exige que a los peces cultivados se les evite el dolor innecesario, angustia o sufrimiento en el sacrificio, y se han desarrollado sistemas manuales y automatizados eficientes para ayudar a alcanzar este objetivo. Además, se ha reportado de una vida de anaquel más duradera y de una mejor calidad de la carne. 

EU legislation requires farmed fish be spared unnecessary pain, distress or suffering at slaughter, and efficient manual and automated systems have been developed to help achieve this goal. What’s more, longer shelf life and improved flesh quality have been reported. 

To assess the role of genetic engineering in agriculture, we should first state what we want from our agricultural systems. Agriculture, and by extension the future of aquaculture, lacks a succinct direction. 

In the first part of a series on genetically modified foods, independent advisor Scott Nichols discusses the simplistic decision behind product labels and the more complex question of what could and should be the outcomes of its use. 

Ron Stotish, CEO of AquaBounty Technologies, discusses being the first to produce a genetically modified (GM) farmed salmon deemed safe for consumption, the controversy surrounding his company's product and the potential of biotechnology. 

Un artículo de FactCheck.org llegó a la conclusión de que los temores sobre el riesgo para la salud humana y para el medio ambiente que plantea el salmón GM carecen de fundamento. Mientras tanto, un grupo de ONG ambientales ha demandado a la Administración de Alimentos y Medicamentos de EE.UU. sobre su aprobación de los peces el año pasado. 

An article by FactCheck.org concluded that fears regarding risk to human and environmental health posed by GM salmon are unfounded. Meanwhile, a group of environmental NGOs has sued the U.S. Food and Drug Administration over its approval of the fish last year. 

Drug-related import refusals at U.S. ports were up in 2015 for the third straight year. Representatives from the National Fisheries Institute and the Food and Drug Administration discussed U.S. aquaculture drug policy at Seafood Expo North America and how the supply chain can avoid problems. 

After a 20-year process, a genetically modified fish earned U.S. Food and Drug Administration approval, reigniting one of the seafood industry’s most intriguing controversies. Here are 10 key downloads from the groundbreaking decision over AquAdvantage salmon. 

Clove oil and eugenol have been recommended and used as anesthetics for several fish species. Moreover, these products have received the attention of researchers because of their chemo-preventive effects, as well as their anti-inflammatory and antioxidant properties. 

Only eight active pharmaceutical ingredients available in 18 drug products have been approved by the U.S. Food and Drug Administration for use in aquaculture. The approval process can be lengthy and expensive. 

If approved by FDA, fast-growing genetically modified salmon will provide a safe and nutritious product similar to other farmed Atlantic salmon. 

Regulations on antibiotics in aquaculture vary by country and region, from outright bans to minimal oversight.